Boyu Hu

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    TG Therapeutics
    Topic:
    Consulting
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/19/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    ADC Therapeutics
    Topic:
    Consulting
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    01/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    OncLive
    Topic:
    Advisory Board
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    10/11/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    MJH Life Sciences
    Topic:
    Educational Session on CAR-T
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    05/04/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bristol Meyer Squibb
    Topic:
    Advisory Board
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    06/03/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    Advisory Board
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    06/18/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Celgene/BMS
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    CRISPR Therapeutics
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    08/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Morphosys Ag
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Repare Therapeutics
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2025

Pages

Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies